On the one hand, CCL21 interacts with CCR7 to control the transfer of immune cells such as DCs and T cells to lymphatic vessels and lymph nodes, which in turn enhances the anti-tumor immune response [201]. The gene discussed is CCL21; the disease is neoplasm.